Langmann T , Lai CC , Weigelt K , Tam BM , Warneke-Wittstock R , Moritz OL , Weber BH .

	Figure 1. Analysis of conserved transcription factor binding sites in the RS1 promoter and delineation of the proximal region. (A) Sequence alignment of the putative RS1 promoter regions from human, dog and mouse. Conserved sequences are highlighted in gray and canonical binding sites for CRX (CRE1 to 3), NR2E3 and NRL (NRE) are boxed. (B) DNA sequence of the putative human RS1 promoter. Potential cis-elements are indicated. An interspersed ALU repeat is italicized. (C) Basal activity of three RS1 promoter–luciferase constructs (−703/+32, −419/+32, −177/+32) and of a PDE6A positive control (−300) transfected into Y79 retinoblastoma cells. RS1 promoter activities are comparable to the PDE6A promoter, which is known to be active in Y79 cells. A schematic of the RS1 promoter is shown with transcription factor binding sites and the ALU repeat (box). Each transfection was repeated three times with duplicate wells analyzed. Error bars represent the standard deviation of the mean from protein normalized luciferase activities.
	Figure 2. RS1 promoter induction levels by CRX, OTX2, NR2E3 and NRL. HEK293 cells were cotransfected with the −177/+32 RS1 promoter–reporter construct and transcription factor expression vectors. X-fold stimulation values were calculated by normalizing CRX, OTX2, NRL and NR2E3 cotransfected cells to mock-vector transfections. CRX (black bars) specifically induces the RS1 promoter in a dose-dependent manner. OTX2 (dark gray bars), NR2E3 (light gray bars) and NRL (white bars) do not induce or suppress the RS1 promoter. Each transfection was repeated three times with duplicate wells analyzed. Error bars represent the standard deviation of the mean from protein normalized luciferase activities.
	Figure 3. CRX, HATs and AcH3 are associated with the RS1 promoter region. (A and B) EMSAs with Y79, mouse retina, BV-2 microglia nuclear extracts or in vitro translated transcription factors. The sequences used for EMSA analysis are shown below with the mutated nucleotides underlined and conserved motifs printed in bold letters. Each gel was loaded with 5 µg of nuclear extracts or 4 µl of in vitro translated proteins, as indicated. Arrows represent specific binding identifiable by shifted bands that were inhibited by excess unlabeled weight or consensus oligonucleotides, but not by their mutant counterparts. Incubation with BV-2 microglia cells nuclear extract (M) did not result in a specific band shift. Addition of 1 µl anti-CRX antibody did not produce a supershift, but specifically inhibited CRX binding to the oligonucleotide. Asterisks indicate unspecific bands. (A) Interaction of RS1 CRE1 and (B) CRE3 with proteins in Y79 cells, mouse retina, BV-2 cells (M) and in vitro translated CRX (IVT). (C) ChIP assays using wild-type Y79 cells or Y79 cells transfected with CRX, NR2E3 or NRL. Immunoprecipitation was carried out with antibodies against CRX, NR2E3 or NRL. Input DNA served as positive control and IP with rabbit IgG antibody served as negative control. The RS1 promoter fragment −177/+130 was analyzed for in vivo CRX, NR2E3 and NRL binding by ChIP–PCR. (D) ChIP assays using wild-type or CRX-transfected Y79 cells with antibodies against CRX, CBP, P300, AcH3 and GCN5. Input DNA served as positive control and IP with rabbit IgG antibody served as negative control. DNA fragments were analyzed by PCR for two different RS1 promoter fragments and the red-cone opsin promoter. The RS1 promoter fragment −177/+130 and the red-cone opsin control promoter displayed ChIP-PCR positive signals whereas the RS1 promoter region −703/−530 lacking CRX sites did not show specific CRX binding.
	Figure 4. Delineation of the critical sequences required for CRX binding and RS1 promoter activity. Luciferase assays were performed with the RS1 wild-type promoter construct −177/+32, and CRE single-, double- and triple mutant promoters in Y79 cells (A) and HEK293 cells cotransfected with CRX (B). The basal luciferase activity of the wild-type contruct −177/+32 (A) or the CRX-induction of the wild-type contruct −177/+32 was set to 100%. Each transfection was repeated three times with duplicate wells analyzed. Error bars represent the standard deviation of the mean from protein normalized luciferase activities.
	Figure 5. In vivo analysis of RS1 promoter–GFP constructs. Confocal micrographs of transgenic X. laevis retinae expressing GFP (green) under the control of various promoters. Cryosections were counterstained with wheat germ agglutinin (red) and Hoechst nuclear stain (blue). (A) Nontransgenic control retina (NON-TG); (B) Xenopus opsin promoter (XOP); (C) RS1 promoter wild type (RS1-WT); (D) RS1 promoter with mutated CRE1 (mCRE1); (E) RS1 promoter with mutated CRE2 (mCRE2); (F) RS1 promoter with mutated CRE1 and CRE3 (mCRE13); (G) RS1 promoter with mutated NRE (mNRE); (H) RS1 promoter with mutated NR2E3 (mNR2E3). GFP was not expressed in the nontransgenic retina but was highly expressed in photoreceptors in the XOP retina. The wild-type RS1 promoter (NON-TG) drives GFP expression in photoreceptors albeit at lower levels. Abolishing NRL and NR2E3 binding did not significantly alter GFP expression (G and H). Mutating the CRE1 site (D and F) reduced GFP expression to below detectable limits, but no obvious effect resulted from mutating the CRE2 site (E). The GFP signals in panels A and C-H are directly comparable as the same laser intensity and amplifier setting were used, and identical image processing was applied. In panel B, the amplifier gain was reduced due to the intensity of the GFP signal. The inset shows an image acquired with settings equivalent to the other panels. Photoreceptor outer segments (os), outer nuclear layer (onl), inner nuclear layer (inl) and inner plexiform layer (ipl). Scale bar, 50 µm.
	Figure 6. RS1 promoter activity in bipolar cells. (A–D) Confocal micrographs of transgenic retinas expressing GFP. (A) Within the retina, the X. laevis opsin promoter drives expression exclusively in rod photoreceptors. In contrast, the RS1 promoter (B) drives expression in both photoreceptors and bipolar cells (asterisks). Mutant RS1 promoters lacking NR2E3 (C) or CRE2 (D) sequences were also capable of driving expression in bipolar cells. Photoreceptor outer segments (os), inner segments (is), outer nuclear layer (onl), outer plexiform layer (opl), inner nuclear layer (inl) and inner plexiform layer (ipl). Scale bar, 20 µm.

Akimoto, Targeting of GFP to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted photoreceptors. 2006, Pubmed

Akimoto, Targeting of GFP to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted photoreceptors. 2006, Pubmed
Blackshaw, Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes. 2001, Pubmed
Chen, Crx, a novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific genes. 1997, Pubmed
Cheng, Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors. 2004, Pubmed
Corbo, A typology of photoreceptor gene expression patterns in the mouse. 2007, Pubmed
Ebert, Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype. 2008, Pubmed
Freund, Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the photoreceptor. 1997, Pubmed
Furukawa, Retinopathy and attenuated circadian entrainment in Crx-deficient mice. 1999, Pubmed
Gehrig, Isolation and characterization of the murine X-linked juvenile retinoschisis (Rs1h) gene. 1999, Pubmed
Grayson, Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. 2000, Pubmed
Haider, Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. 2000, Pubmed , Xenbase
Haider, Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. 2001, Pubmed
Hennig, Regulation of photoreceptor gene expression by Crx-associated transcription factor network. 2008, Pubmed
Hsiau, The cis-regulatory logic of the mammalian photoreceptor transcriptional network. 2007, Pubmed
Janssen, Effect of late-stage therapy on disease progression in AAV-mediated rescue of photoreceptor cells in the retinoschisin-deficient mouse. 2008, Pubmed
Kroll, Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. 1996, Pubmed , Xenbase
Livesey, Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx. 2000, Pubmed
Mears, Nrl is required for rod photoreceptor development. 2001, Pubmed
Min, Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. 2005, Pubmed
Mitton, The leucine zipper of NRL interacts with the CRX homeodomain. A possible mechanism of transcriptional synergy in rhodopsin regulation. 2000, Pubmed
Molday, Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex. 2007, Pubmed
Molday, Expression of X-linked retinoschisis protein RS1 in photoreceptor and bipolar cells. 2001, Pubmed
Moritz, Fluorescent photoreceptors of transgenic Xenopus laevis imaged in vivo by two microscopy techniques. 1999, Pubmed , Xenbase
Moritz, Selection of transgenic Xenopus laevis using antibiotic resistance. 2002, Pubmed , Xenbase
Palhan, Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. 2005, Pubmed
Peng, The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes. 2005, Pubmed
Peng, Chromatin immunoprecipitation identifies photoreceptor transcription factor targets in mouse models of retinal degeneration: new findings and challenges. 2005, Pubmed
Pittler, Functional analysis of the rod photoreceptor cGMP phosphodiesterase alpha-subunit gene promoter: Nrl and Crx are required for full transcriptional activity. 2004, Pubmed
Podvinec, NUBIScan, an in silico approach for prediction of nuclear receptor response elements. 2002, Pubmed
Qian, Identification of regulatory targets of tissue-specific transcription factors: application to retina-specific gene regulation. 2005, Pubmed
Rath, Ontogenetic expression of the Otx2 and Crx homeobox genes in the retina of the rat. 2007, Pubmed
Reid, The mouse X-linked juvenile retinoschisis cDNA: expression in photoreceptors. 1999, Pubmed
Reid, Retinoschisin, a photoreceptor-secreted protein, and its interaction with bipolar and muller cells. 2003, Pubmed
Roesch, The natural history of X-linked retinoschisis. 1998, Pubmed
Sauer, Positional cloning of the gene associated with X-linked juvenile retinoschisis. 1997, Pubmed
Takada, Retinoschisin expression and localization in rodent and human pineal and consequences of mouse RS1 gene knockout. 2006, Pubmed
Takada, Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery. 2008, Pubmed
Takada, A retinal neuronal developmental wave of retinoschisin expression begins in ganglion cells during layer formation. 2004, Pubmed
Vogel, Sensing extracellular matrix: an update on discoidin domain receptor function. 2006, Pubmed
Weigelt, Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. 2007, Pubmed
Wu, RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. 2005, Pubmed
Wu, Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. 2003, Pubmed
Yoshida, Expression profiling of the developing and mature Nrl-/- mouse retina: identification of retinal disease candidates and transcriptional regulatory targets of Nrl. 2004, Pubmed
Zeng, RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis. 2004, Pubmed